Prediction #1: More Lawsuits Due to Adverse Effects The number of lawsuits against GLP-1 companies (like Novo Nordisk and Eli Lilly) has grown significantly, expanding from just 55 consolidated cases in early 2024 to more than 4,400 total cases by mid-2026 When I wrote the original piece, news outlets were reporting a few dozen lawsuits against manufacturers Novo Nordisk and Eli Lilly
Others wait two weeks
org/10.1101/2023.02.10.524960 Averill-Bates, D
Clinical trials evaluate medications through different types of endpoints
Can I set up automatic Ozempic refills
Safety Considerations, Monitoring, and Who Benefits from Long-Term Maintenance Long-term semaglutide maintenance requires ongoing medical oversight, including periodic assessment of gastrointestinal tolerance, glycemic control, cardiovascular markers, kidney function, and thyroid health